TickerFacts.

Company research / AVAH

Aveanna Healthcare Holdings, Inc. (AVAH)

Build a valuation ↗↓ Download CSV

CIK 0001832332 · Nasdaq · Services-Home Health Care Services

  • Sector Services
  • Incorporated DE
  • Fiscal year ends around Jan 1

For the year ended 2026-01-03 (fiscal 2025), Aveanna Healthcare Holdings, Inc. reported revenue of $2.43B. Revenue grew 20.2% from the prior annual period. Over the twelve months to 2026-07-04, revenue was $2.60B.

Key ratios (year ended 2026-01-03, fiscal 2025)

33.3%
Gross margin
10.5%
Operating margin
9.2%
Net margin
115.7%
Return on year-end equity
20.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-04 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-04		2026-01-03, Fiscal 20252024-12-282023-12-302022-12-312022-01-01, Fiscal 20212021-01-02, Fiscal 20202019-12-28
Revenue$2.60B$2.43B$2.02B$1.90B$1.79B$1.68B$1.50B$1.38B
Gross Profit$840.08M$810.48M$635.54M$595.43M$553.23M$542.40M$454.51M$419.25M
Operating Income$273.93M$256.46M$139.79M$8.07M-$642.28M-$36.11M-$3.49M$38.95M
Depreciation & Amortization$11.22M$10.54M$10.78M$13.78M$21.31M$20.55M$17.03M$14.32M
EBITDA$285.15M$267.00M$150.56M$21.85M-$620.96M-$15.56M$13.54M$53.27M
Net Income$274.76M$225.03M-$10.93M-$134.52M-$662.03M-$117.04M-$57.05M-$76.52M
EPS (Diluted)n/a$1.05-$0.06-$0.71-$3.57-$0.69n/an/a
Total Assets$2.11B$2.01B$1.66B$1.61B$1.71B$2.33B$1.84Bn/a
Total Liabilities$1.82B$1.82B$1.79B$1.74B$1.72B$1.70B$1.58Bn/a
Long-Term Debt$1.30B$1.30B$1.28B$1.29B$1.29B$1.24B$1.17Bn/a
Shareholders' Equity$287.28M$194.46M-$123.55M-$129.57M-$6.31M$635.82M$265.03M$270.19M
Cash & Equivalents$97.20M$193.26M$84.29M$43.94M$19.22M$30.49M$137.34Mn/a
Operating Cash Flow$168.20M$125.86M$32.64M$22.67M-$48.40M-$11.35M$116.62M-$8.71M
Capital Expendituresn/an/an/an/an/a$15.95M$15.24M$16.64M
Free Cash Flown/an/an/an/an/a-$27.30M$101.38M-$25.35M
Shares Outstanding218.15M211.00M193.23M190.73M188.86M184.73M141.93Mn/a
Weighted Average Diluted Sharesn/a214.98M192.89M189.96M185.55Mn/an/an/a
EPS (Basic)n/a$1.11-$0.06-$0.71-$3.57-$0.69n/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView